Angela Webster, MBBS, talks about why only certain patients should be screened for cancer post-transplant.
Obese individuals often are rejected as renal transplant candidates in large part because of their increased risk for surgical complications and adverse outcomes.
In adjusted analyses, female transplant recipients had a significantly increased risk of urologic cancer and men did not.
Graft survival was similar to that seen in concurrent single SCD kidney recipients
Improved renal function may contribute to the decline in a glycoprotein that inhibits bone formation.
Patients are more likely to receive a kidney transplant and less likely to die than patients with end-stage renal disease from other causes.
Black female hemodialysis patients less likely to want living transplant; more likely to receive offer.
For some highly sensitized patients, expanded criteria donor kidneys do not confer a survival edge over standard criteria donor kidneys.
Kidney transplanted from brain-dead donors or those who died from circulatory causes are associated with similar patient and graft survival.
Study compared single-dose alemtuzumab and multiple-dose rabbit anti-thymocyte globulin.
Using cephalexin instead of trimethoprim-sulfamethoxazole may decrease UTI incidence and cost of care.
Less than a high school education and delayed graft function are among the factors that increase the risk of readmission within 30 days.
A pre-transplant history of malignancy increases the 10-year post-transplant mortality risk by 22%.
Mean estimated glomerular filtration rate decreases by 0.57 mL/min/1.73 m2 annually with each 1-year increase in age at donation.
In a study, donors were 60% more likely to be diagnosed with gout than matched healthy controls.
They also are at elevated risk of cardiovascular and all-cause mortality, study finds.
No differences found in mortality, CVD between donors, nondonors older than 55.